VXB Vaccines

Vaxbio is a biotechnology company focused on the development of next-generation vaccines targeting difficult-to-treat bacterial infections, with a primary emphasis on Staphylococcus aureus. The company utilizes a proprietary platform to design recombinant protein vaccines that aim to provide broad protection against various strains of the pathogen. Its lead candidate, VXB-001, is designed to address the significant unmet medical need in preventing hospital-acquired and community-associated staphylococcal infections. Vaxbio's approach combines advanced protein engineering with immunological insights to overcome the historical challenges associated with S. aureus vaccine development.